COM:NEUMORATX
Neumora Therapeutics, Inc.
- Stock
Last Close
9.69
22/11 21:00
Market Cap
1.72B
Beta: -
Volume Today
490.17K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '20 | Mar '21 | Jun '21 | Sep '21 | Dec '21 | Mar '22 | Jun '22 | Sep '22 | Dec '22 | Mar '23 | Jun '23 | Sep '23 | Dec '23 | Mar '24 | Jun '24 | Sep '24 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | |||||||||||||||||
cost of revenue | 160K - | ||||||||||||||||
gross profit | -160K - | ||||||||||||||||
selling and marketing expenses | |||||||||||||||||
general and administrative expenses | 4.29M - | 3.94M 8.22% | 6.31M 59.97% | 6.66M 5.63% | 7.64M 14.67% | 8.09M 5.88% | 7.79M 3.72% | 8.05M 3.43% | 7.20M 10.65% | 9.68M 34.58% | 9.29M 4.03% | 15.26M 64.24% | 11.24M 26.38% | 14.32M 27.42% | 16.02M - | ||
selling general and administrative expenses | 4.29M - | 3.94M 8.22% | 6.31M 59.97% | 6.66M 5.63% | 7.64M 14.67% | 8.09M 5.88% | 7.79M 3.72% | 8.05M 3.43% | 7.20M 10.65% | 9.68M 34.58% | 9.29M 4.03% | 15.26M 64.24% | 11.24M 26.38% | 14.32M 27.42% | 15.03M 5.01% | 16.02M 6.53% | |
research and development expenses | 15.23M - | 11.50M 24.49% | 10.89M 5.29% | 171.47M 1,473.99% | 18.91M 88.97% | 35.15M 85.89% | 23.53M 33.06% | 22.55M 4.16% | 23.52M 4.32% | 29.48M 25.35% | 32.77M 11.14% | 41.60M 26.95% | 102.77M 147.03% | 45.76M 55.48% | 48.63M 6.27% | 60.63M 24.68% | |
other expenses | -470K - | 141K 130% | 189K 34.04% | 103K 45.50% | -422K 509.71% | 108K 125.59% | 158K 46.30% | -148K 193.67% | 287K 293.92% | -26K 109.06% | -39K 50% | -1K 97.44% | -104K 10,300% | -12K 88.46% | |||
cost and expenses | 19.53M - | 15.45M 20.91% | 17.20M 11.36% | 178.13M 935.65% | 26.55M 85.10% | 43.24M 62.87% | 31.31M 27.57% | 30.60M 2.27% | 30.72M 0.38% | 39.17M 27.51% | 42.06M 7.39% | 56.86M 35.19% | 114.00M 100.49% | 60.07M 47.31% | 63.82M 6.24% | 76.65M 20.09% | |
operating expenses | 19.53M - | 15.45M 20.91% | 17.20M 11.36% | 178.13M 935.65% | 26.55M 85.10% | 43.24M 62.87% | 31.31M 27.57% | 30.60M 2.27% | 30.72M 0.38% | 39.17M 27.51% | 42.06M 7.39% | 56.86M 35.19% | 114.00M 100.49% | 60.07M 47.31% | 63.66M 5.97% | 76.65M 20.40% | |
interest expense | |||||||||||||||||
ebitda | -19.46M - | -15.31M 21.33% | -17.07M 11.51% | -177.98M 942.35% | -26.42M 85.16% | -43.09M 63.12% | -31.16M 27.68% | -30.46M 2.26% | -30.57M 0.38% | -39.01M 27.60% | -41.89M 7.39% | -56.86M 35.74% | -113.84M 100.19% | -59.92M 47.37% | -63.66M 6.25% | -76.49M 20.15% | |
operating income | -19.53M - | -15.45M 20.91% | -17.20M 11.36% | -178.13M 935.65% | -26.55M 85.10% | -43.24M 62.87% | -31.31M 27.57% | -30.60M 2.27% | -30.72M 0.38% | -39.17M 27.51% | -42.06M 7.39% | -56.86M 35.19% | -114.00M 100.49% | -60.07M 47.31% | -63.82M 6.24% | -76.65M 20.09% | |
depreciation and amortization | 63K - | 132K 109.52% | 125K 5.30% | 150K 20% | 131K 12.67% | 147K 12.21% | 154K 4.76% | 146K 5.19% | 147K 0.68% | 158K 7.48% | 171K 8.23% | 173K 1.17% | 166K 4.05% | 158K 4.82% | 160K 1.27% | 156K 2.50% | |
total other income expenses net | -470K - | 141K 130% | 189K 34.04% | 103K 45.50% | -422K 509.71% | 108K 125.59% | 158K 46.30% | -148K 193.67% | 287K 293.92% | -26K 109.06% | -39K 50% | -1K 97.44% | -104K 10,300% | -12K 88.46% | 5.25M 43,825% | 4.15M 20.87% | |
income before tax | -20.00M - | -15.30M 23.47% | -17.01M 11.15% | -178.03M 946.55% | -26.97M 84.85% | -43.04M 59.60% | -30.37M 29.44% | -29.34M 3.38% | -28.15M 4.08% | -35.63M 26.57% | -38.54M 8.19% | -53.03M 37.58% | -108.46M 104.54% | -53.72M 50.47% | -58.58M 9.04% | -72.49M 23.76% | |
income tax expense | -86K - | -784K 811.63% | -1.41M 79.34% | -2.29M 62.52% | -3.57M 56.19% | -3.56M 0.31% | -4.01M 12.73% | -5.38M 34.08% | -6.37M 18.35% | 125K 101.96% | 53K 57.60% | ||||||
net income | -20.00M - | -15.30M 23.47% | -17.01M 11.15% | -178.03M 946.55% | -26.97M 84.85% | -43.04M 59.60% | -30.37M 29.44% | -29.34M 3.38% | -28.15M 4.08% | -35.63M 26.57% | -38.54M 8.19% | -53.03M 37.58% | -108.73M 105.05% | -53.72M 50.59% | -58.70M 9.27% | -72.55M 23.59% | |
weighted average shs out | 151.95M - | 151.95M - | 151.95M - | 151.95M - | 151.95M 0.00% | 46.69M 69.27% | 157.94M - | 158.98M 0.66% | 159.58M 0.37% | ||||||||
weighted average shs out dil | 151.95M - | 151.95M - | 151.95M - | 151.95M - | 151.95M 0.00% | 46.69M 69.27% | 157.94M - | 158.98M 0.66% | 159.58M 0.37% | ||||||||
eps | 0 - | -0.10 Infinity% | 0 100% | 0 | 0 | -0.28 Infinity% | 0 100% | -0.19 Infinity% | 0 100% | -0.23 Infinity% | -0.49 112.22% | -1.14 133.55% | 0 100% | -0.34 Infinity% | -0.37 8.82% | -0.45 21.62% | |
epsdiluted | 0 - | -0.10 Infinity% | 0 100% | 0 | 0 | -0.28 Infinity% | 0 100% | -0.19 Infinity% | 0 100% | -0.23 Infinity% | -0.49 112.22% | -1.14 133.55% | 0 100% | -0.34 Infinity% | -0.37 8.82% | -0.45 21.62% |
All numbers in USD (except ratios and percentages)